Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RMD open

Showing results (1-10 of 2,081) with videos related to

Pageof 209
Sort By:
RMD Open|May 6, 2022
Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countriesFlorian Lucasson, Uta Kiltz, Umut Kalyoncu, et al.
RMD Open|May 6, 2022
Heterogeneity of axial spondyloarthritis: genetics, sex and structural damage matterZhixiu Li, Sjef M van der Linden, Muhammad Asim Khan, et al.
RMD Open|November 23, 2022
Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registryHafsah Nabi, Oliver Hendricks, Dorte Vendelbo Jensen, et al.
RMD Open|January 21, 2020
Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational studyAlain Saraux, René-Marc Flipo, Francis Fagnani, et al.
RMD Open|January 21, 2020
Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritisPrzemysław Błyszczuk, Zoltan Szekanecz
RMD Open|January 21, 2020
Exploring healthcare professionals' knowledge, attitudes and experiences of shared decision making in rheumatologyElke G E Mathijssen, Bart J F van den Bemt, Sabien Wielsma, et al.
RMD Open|January 21, 2020
<i>​</i>Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatmentAnnette de Thurah, Ina Trolle Andersen, Andreas Bugge Tinggaard, et al.
RMD Open|June 11, 2021
Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKLKaterina Chatzidionysiou, Alexandra Circiumaru, Bence Rethi, et al.
RMD Open|June 15, 2023
Correction: 'It surprised me a lot that there is a link': a qualitative study of the acceptability of periodontal treatment for individuals at risk of rheumatoid arthritis
RMD Open|June 15, 2023
Correction: Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study
Pageof 209

Showing results (1-10 of 2,081) with videos related to

Sort By:
Pageof 209
RMD Open|May 6, 2022
Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countriesFlorian Lucasson, Uta Kiltz, Umut Kalyoncu, et al.
RMD Open|May 6, 2022
Heterogeneity of axial spondyloarthritis: genetics, sex and structural damage matterZhixiu Li, Sjef M van der Linden, Muhammad Asim Khan, et al.
RMD Open|November 23, 2022
Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registryHafsah Nabi, Oliver Hendricks, Dorte Vendelbo Jensen, et al.
RMD Open|January 21, 2020
Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational studyAlain Saraux, René-Marc Flipo, Francis Fagnani, et al.
RMD Open|January 21, 2020
Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritisPrzemysław Błyszczuk, Zoltan Szekanecz
RMD Open|January 21, 2020
Exploring healthcare professionals' knowledge, attitudes and experiences of shared decision making in rheumatologyElke G E Mathijssen, Bart J F van den Bemt, Sabien Wielsma, et al.
RMD Open|January 21, 2020
<i>​</i>Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatmentAnnette de Thurah, Ina Trolle Andersen, Andreas Bugge Tinggaard, et al.
RMD Open|June 11, 2021
Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKLKaterina Chatzidionysiou, Alexandra Circiumaru, Bence Rethi, et al.
RMD Open|June 15, 2023
Correction: 'It surprised me a lot that there is a link': a qualitative study of the acceptability of periodontal treatment for individuals at risk of rheumatoid arthritis
RMD Open|June 15, 2023
Correction: Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study
Pageof 209